Fed. Circ. Affirms Cephalon Win In Generic Fentora IP Suit
The Federal Circuit on Thursday upheld a Delaware court's ruling that Watson Pharmaceuticals Inc.'s proposed generic version of Fentora infringes Cephalon Inc.'s patent for the painkiller....To view the full article, register now.
Already a subscriber? Click here to view full article